Biointron x Scientist.com Webinar: Accelerating Antibody Discovery: Integrating Microfluidics, HT Expression, and Early Developability Platform

When

April 30, 2026, 11:00 AM ET

Register here >>

About

Increasingly, antibody drug development requires quick and holistic assessment from the discovery stage with a powerful platform, which demands experienced scientists make smart and strategic choices. We will discuss how Biointron‘s unique single B cell sorting-based antibody screening can help identify a population of diverse and functional hits with a shortened timeline. Integrated with our high-throughput expression, validation and developability assay platforms, the path from hits to candidate can be more faster and more efficient with data beyond binding alone.

Register here >>

Seminar Objectives

• Antibody discovery platforms in action

• Faster, smarter early-stage decision-making

• Rapid identification of diverse, functional hits via single B cell screening

• Accelerated path from hits to candidates with integrated, data-rich workflows

Register here >>

About the Speaker

Lei Shi, PhD, Senior Vice President at Biointron

Lei Shi, PhD. is Senior Vice President of Biointron. He has more than 20 years of experience in antibody discovery. Previously, Lei worked for a number of pharmaceutical and biotech companies such as Johnson & Johnson with increasing responsibilities. He completed his postdoc research at MGH and Harvard Medical School and has an Executive Master's degree from the University of Pennsylvania.

Register here >>